학술논문

Pemigatinib for metastatic or surgically unresectable urothelial carcinoma with FGF/FGFR genomic alterations: final results from FIGHT-201
Document Type
Article
Source
In Annals of Oncology February 2024 35(2):200-210
Subject
Urogenital tumors
Language
ISSN
0923-7534